Roger L Pang

Array ( [id] => 3619158 [patent_doc_number] => 05614393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Production of .gamma.-linolenic acid by a .DELTA.6-desaturase' [patent_app_type] => 1 [patent_app_number] => 8/366779 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 9753 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614393.pdf [firstpage_image] =>[orig_patent_app_number] => 366779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854671 [patent_doc_number] => 05767366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Mutant acetolactate synthase gene from Ararbidopsis thaliana for conferring imidazolinone resistance to crop plants' [patent_app_type] => 1 [patent_app_number] => 8/363208 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 8253 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767366.pdf [firstpage_image] =>[orig_patent_app_number] => 363208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3740028 [patent_doc_number] => 05786214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system' [patent_app_type] => 1 [patent_app_number] => 8/356703 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4169 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786214.pdf [firstpage_image] =>[orig_patent_app_number] => 356703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855263 [patent_doc_number] => 05705389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Oligonucleotides that inhibit production of .alpha.-tumor necrosis factor' [patent_app_type] => 1 [patent_app_number] => 8/342338 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3114 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705389.pdf [firstpage_image] =>[orig_patent_app_number] => 342338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3897992 [patent_doc_number] => 05750666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Polynucleotide phosphorodithioate compounds' [patent_app_type] => 1 [patent_app_number] => 8/332829 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750666.pdf [firstpage_image] =>[orig_patent_app_number] => 332829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872649 [patent_doc_number] => 05824550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Voltage-gated calcium channel and antisense oligonucleotides thereto' [patent_app_type] => 1 [patent_app_number] => 8/330433 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8464 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824550.pdf [firstpage_image] =>[orig_patent_app_number] => 330433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657615 [patent_doc_number] => 05658891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Oligonucleotide therapies for modulating the effects of herpesviruses' [patent_app_type] => 1 [patent_app_number] => 8/329212 [patent_app_country] => US [patent_app_date] => 1994-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 8148 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658891.pdf [firstpage_image] =>[orig_patent_app_number] => 329212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658749 [patent_doc_number] => 05591721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Method of down-regulating gene expression' [patent_app_type] => 1 [patent_app_number] => 8/328520 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 7184 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591721.pdf [firstpage_image] =>[orig_patent_app_number] => 328520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3495330 [patent_doc_number] => 05532143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Isolated DNA molecules for intergration site independent gene expression in mammalian host cells' [patent_app_type] => 1 [patent_app_number] => 8/312498 [patent_app_country] => US [patent_app_date] => 1994-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12214 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532143.pdf [firstpage_image] =>[orig_patent_app_number] => 312498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585601 [patent_doc_number] => 05552306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Production of .gamma.-linolenic acid by a .DELTA.6-desaturase' [patent_app_type] => 1 [patent_app_number] => 8/307382 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6390 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552306.pdf [firstpage_image] =>[orig_patent_app_number] => 307382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658745 [patent_doc_number] => 05623049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics' [patent_app_type] => 1 [patent_app_number] => 8/300884 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11703 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/623/05623049.pdf [firstpage_image] =>[orig_patent_app_number] => 300884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854433 [patent_doc_number] => 05705333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Peptide-based nucleic acid mimics(PENAMS)' [patent_app_type] => 1 [patent_app_number] => 8/286875 [patent_app_country] => US [patent_app_date] => 1994-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26635 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705333.pdf [firstpage_image] =>[orig_patent_app_number] => 286875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858037 [patent_doc_number] => 05792645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Protein-polycation nucleic acid complexes and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/254888 [patent_app_country] => US [patent_app_date] => 1994-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 24 [patent_no_of_words] => 11434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792645.pdf [firstpage_image] =>[orig_patent_app_number] => 254888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693593 [patent_doc_number] => 05650316 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Uses of triplex forming oligonucleotides for the treatment of human diseases' [patent_app_type] => 1 [patent_app_number] => 8/254114 [patent_app_country] => US [patent_app_date] => 1994-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 14 [patent_no_of_words] => 5619 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650316.pdf [firstpage_image] =>[orig_patent_app_number] => 254114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855071 [patent_doc_number] => 05705375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Transgenic plants having a modified carbohydrate content' [patent_app_type] => 1 [patent_app_number] => 8/253575 [patent_app_country] => US [patent_app_date] => 1994-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10369 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705375.pdf [firstpage_image] =>[orig_patent_app_number] => 253575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549145 [patent_doc_number] => 05571713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Therapeutic treatment for inhibiting vascular restenosis' [patent_app_type] => 1 [patent_app_number] => 8/250958 [patent_app_country] => US [patent_app_date] => 1994-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6509 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571713.pdf [firstpage_image] =>[orig_patent_app_number] => 250958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3796241 [patent_doc_number] => 05827703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Methods and composition for in vivo gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/246376 [patent_app_country] => US [patent_app_date] => 1994-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 84 [patent_no_of_words] => 18802 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827703.pdf [firstpage_image] =>[orig_patent_app_number] => 246376 [rel_patent_id] =>[rel_patent_doc_number] =>)